Trade GH stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Guardant Health, Inc. (GH) is trading at US$179.38, down 2.03% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$22.91B. Over the past 52 weeks, GH has traded between US$55.38 and US$183.51. On Syfe you can trade GH with $0 commission and add it to your watchlist.
| Previous close | US$183.10 |
|---|---|
| Market cap | US$22.91B |
| 52-week range | US$55.38 – US$183.51 |
| Volume | 3.08M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Guardant Health, Inc.
Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.
Year: 2018
Guardant Health, Inc. (GH) stock is trading at US$179.38, -2.03% from the previous close of US$183.10.
The market cap for Guardant Health, Inc. (GH) stock is approximately US$22.91B.
The 52-week high for Guardant Health, Inc. (GH) stock is US$183.51.
The 52-week low for Guardant Health, Inc. (GH) stock is US$55.38.
Guardant Health, Inc. (GH) does not currently pay a dividend.
Stay on top of GH
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
